T1	Participants 79 153	acute moderate to severe asthma in children between 5 and 15 years of age:
T2	Participants 315 346	acute moderate to severe asthma
T3	Participants 405 478	Emergency room/outpatient paediatric services of a tertiary care hospital
T4	Participants 489 677	Children aged 5-15 years (without prior use of montelukast) with acute moderate to severe asthma exacerbation, as defined using Modified Pulmonary Index Score (MPIS) > or =9, were enrolled
T5	Participants 1069 1159	117 children (60 in montelukast group and 57 in placebo group) were enrolled in the study.
T6	Participants 1691 1737	children with acute moderate to severe asthma.